Also trades as: GALE.SW (SIX) · $vol 8M · 0ROG.L (LSE) · $vol 2M

$98.27

+0.27 (+0.27%)

Weekly Expected Move ±6.6%

$85 $92 $98 $105 $111

OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 39 · $4.9B mcap · 50M float · 0.0011% daily turnover · Short 100% of daily vol

Revenue

$4.1B +5.5% ▲

5Y CAGR: +3.5%

Gross Profit

$429M -60.5% ▼

5Y CAGR: +4.2%

Operating Income

$223M +9.1% ▲

5Y CAGR: +2.0%

Net Income

$181M -1.0% ▼

5Y CAGR: +1.0%

EPS (Diluted)

$3.63 -1.1% ▼

5Y CAGR: +0.8%

EBITDA

$339M +0.7% ▲

5Y CAGR: +2.3%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.8B	$4.0B	$3.7B	$3.9B	$4.1B
YoY Growth	+10.2%	+4.7%	-6.7%	+4.7%	+5.5%
Cost of Revenue	$3.5B	$3.6B	$3.3B	$2.8B	$3.7B
Gross Profit	$351M	$374M	$451M	$1.1B	$429M
Gross Margin	9.1%	9.3%	12.0%	27.7%	10.4%
R&D Expenses	$15M	$14M	$13M	$0	$8M
SG&A Expenses	$75M	$82M	$100M	$83M	$196M
Operating Expenses	$164M	$181M	$1.0B	$883M	$206M
Operating Income	$186M	$193M	$191M	$204M	$223M
Operating Margin	4.9%	4.8%	5.1%	5.2%	5.4%
Interest Expense	$6M	$6M	$16M	$13M	$16M
Income Before Tax	$196M	$195M	$195M	$215M	$222M
Tax Expense	$35M	$34M	$29M	$31M	$39M
Net Income	$168M	$165M	$174M	$183M	$181M
Net Margin	4.4%	4.1%	4.6%	4.7%	4.4%
EPS (Diluted)	$3.38	$3.32	$5.72	$3.67	$3.63
EBITDA	$300M	$290M	$307M	$337M	$339M
Shares Outstanding	50M	50M	50M	50M	50M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$2.1B	$1.9B	$1.9B	$1.9B	$2.0B	$2.0B	$2.1B	$2.1B
Cost of Revenue	$1.9B	$1.7B	$1.7B	$1.7B	$1.1B	$1.7B	$1.9B	$1.9B
Gross Profit	$188M	$182M	$196M	$192M	$896M	$255M	$228M	$193M
Gross Margin	9.2%	9.8%	10.3%	10.1%	44.5%	12.7%	10.6%	9.1%
R&D Expenses	$14M	$0	$13M	$0	$0	$0	$0	$0
SG&A Expenses	$96M	$100M	$102M	$91M	-$8M	$0	$113M	$117M
Operating Expenses	$90M	$92M	$93M	$141M	$742M	$0	$107M	$110M
Operating Income	$98M	$90M	$103M	$100M	$104M	$255M	$121M	$83M
Operating Margin	4.8%	4.8%	5.4%	5.3%	5.2%	12.7%	5.6%	3.9%
Interest Expense	$3M	$4M	$10M	$6M	$7M	$0	$7M	$7M
Income Before Tax	$97M	$87M	$102M	$96M	$118M	$107M	$116M	$80M
Tax Expense	$16M	$15M	$14M	$19M	$12M	$18M	$21M	$13M
Net Income	$82M	$187M	$98M	$79M	$104M	$88M	$93M	$66M
Net Margin	4.0%	10.1%	5.2%	4.1%	5.2%	4.4%	4.3%	3.1%
EPS (Diluted)	$1.65	$3.75	$1.97	$1.58	$2.09	$1.77	$1.86	$1.33
EBITDA	$151M	$142M	$163M	$129M	$210M	$134M	$182M	$166M
Shares Outstanding	50M	50M	50M	50M	50M	50M	50M	50M

GALNF OTC